Comparison of clinical features of patients with aMCD who died vs those who survived
| . | Survivor patients . | Deceased patients . | P value . |
|---|---|---|---|
| Sex, male, n (%) | 57 (53.3%) | 3 (42.9%) | .593 |
| Age at diagnosis of aMCD, y | 50.7 ± 18.9 | 43.0 ± 15.9 | .222 |
| Involvement of both sides of the diaphragm, n (%) | 24 (22.4%) | 3 (42.9%) | .218 |
| HV subtype, n (%) | 53 (60.3%) | 2 (40.0%) | .371 |
| Receiving treatment for aMCD, n (%) | 42 (39.3%) | 1 (14.3%) | .187 |
| Transformation to iMCD, n (%) | 3 (2.8%) | 3 (42.9%) | <.001 |
| . | Survivor patients . | Deceased patients . | P value . |
|---|---|---|---|
| Sex, male, n (%) | 57 (53.3%) | 3 (42.9%) | .593 |
| Age at diagnosis of aMCD, y | 50.7 ± 18.9 | 43.0 ± 15.9 | .222 |
| Involvement of both sides of the diaphragm, n (%) | 24 (22.4%) | 3 (42.9%) | .218 |
| HV subtype, n (%) | 53 (60.3%) | 2 (40.0%) | .371 |
| Receiving treatment for aMCD, n (%) | 42 (39.3%) | 1 (14.3%) | .187 |
| Transformation to iMCD, n (%) | 3 (2.8%) | 3 (42.9%) | <.001 |